12-110626360-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001082538.3(TCTN1):c.342-2A>G variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.000000704 in 1,419,522 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 30)
Exomes 𝑓: 7.0e-7 ( 0 hom. )
Consequence
TCTN1
NM_001082538.3 splice_acceptor, intron
NM_001082538.3 splice_acceptor, intron
Scores
4
1
2
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 6.36
Genes affected
TCTN1 (HGNC:26113): (tectonic family member 1) This gene encodes a member of a family of secreted and transmembrane proteins. The orthologous gene in mouse functions downstream of smoothened and rab23 to modulate hedgehog signal transduction. This protein is a component of the tectonic-like complex, which forms a barrier between the ciliary axoneme and the basal body. A mutation in this gene was found in a family with Joubert syndrome-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-110626360-A-G is Pathogenic according to our data. Variant chr12-110626360-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 183312.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-110626360-A-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCTN1 | NM_001082538.3 | c.342-2A>G | splice_acceptor_variant, intron_variant | ENST00000397659.9 | NP_001076007.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCTN1 | ENST00000397659.9 | c.342-2A>G | splice_acceptor_variant, intron_variant | 1 | NM_001082538.3 | ENSP00000380779.4 | ||||
TCTN1 | ENST00000551590.5 | c.342-2A>G | splice_acceptor_variant, intron_variant | 1 | ENSP00000448735.1 | |||||
TCTN1 | ENST00000397655.7 | c.342-2A>G | splice_acceptor_variant, intron_variant | 1 | ENSP00000380775.3 | |||||
TCTN1 | ENST00000397656.8 | n.342-2A>G | splice_acceptor_variant, intron_variant | 2 | ENSP00000380776.4 | |||||
TCTN1 | ENST00000480648.5 | n.342-2A>G | splice_acceptor_variant, intron_variant | 5 | ENSP00000437196.1 | |||||
TCTN1 | ENST00000495659.6 | n.*100-2A>G | splice_acceptor_variant, intron_variant | 2 | ENSP00000436673.2 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
GnomAD4 exome AF: 7.04e-7 AC: 1AN: 1419522Hom.: 0 Cov.: 31 AF XY: 0.00000142 AC XY: 1AN XY: 703006
GnomAD4 exome
AF:
AC:
1
AN:
1419522
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
703006
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Joubert syndrome 13 Pathogenic:4
Pathogenic, criteria provided, single submitter | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 17, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | May 05, 2020 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Pathogenic, no assertion criteria provided | clinical testing | Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City | May 06, 2020 | - - |
Pathogenic, criteria provided, single submitter | research | UW Hindbrain Malformation Research Program, University of Washington | Feb 23, 2015 | - - |
Global developmental delay;CN228298:Typical Joubert syndrome MRI findings Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Dec 01, 2014 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Benign
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 11
DS_AL_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at